Climb Bio, Inc. (CLYM)
10.94
-0.13
(-1.17%)
USD |
NASDAQ |
Oct 02, 16:00
11.10
+0.16
(+1.46%)
Pre-Market: 08:59
Climb Bio Total Assets (Quarterly) : 246.29M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 246.29M |
| March 31, 2026 | 152.37M |
| December 31, 2025 | 167.74M |
| September 30, 2025 | 182.30M |
| June 30, 2025 | 192.39M |
| March 31, 2025 | 200.74M |
| December 31, 2024 | 217.19M |
| September 30, 2024 | 222.20M |
| June 30, 2024 | 226.02M |
| March 31, 2024 | 109.33M |
| December 31, 2023 | 110.47M |
| Date | Value |
|---|---|
| September 30, 2023 | 112.74M |
| June 30, 2023 | 116.27M |
| March 31, 2023 | 122.08M |
| December 31, 2022 | 134.99M |
| September 30, 2022 | 140.86M |
| June 30, 2022 | 150.10M |
| March 31, 2022 | 162.42M |
| December 31, 2021 | 173.24M |
| September 30, 2021 | 182.25M |
| June 30, 2021 | 107.63M |
| March 31, 2021 | 53.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 6.93M |
| Cullinan Therapeutics, Inc. | 363.79M |
| Q32 Bio, Inc. | 115.87M |
| Artiva Biotherapeutics, Inc. | 368.63M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.747M |
| Shareholders Equity (Quarterly) | 239.55M |
| Debt to Equity Ratio | 0.0055 |
| Current Ratio | 31.45 |
| Net Debt Paydown Yield | -0.02% |